Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.

Ä¡°ú Áø·á½Ç¿¡¼­ÀÇ ½Å¼Ó ±¸°­ Á¡¸· µµ¸» HIV Ç×ü °Ë»ç¿¡ ´ëÇÑ Åµµ ¹× Áö½Ä¿¡ °üÇÑ ¿¬±¸

Attitudes about rapid Oral HIV screening test in dental clinics

´ëÇÑÄ¡°úÀÇ»çÇùȸÁö 2009³â 47±Ç 5È£ p.291 ~ 296
¹ÚÁ¤Ã¶, ±è¿ëÅÂ, Á¤ÀÓÈñ, ¾öÀ¯Á¤, Á¤ÀÇ¿ø, ±è⼺, Á¶±Ô¼º, äÁß±Ô, ±èÁ¾°ü, ÃÖ¼ºÈ£,
¼Ò¼Ó »ó¼¼Á¤º¸
¹ÚÁ¤Ã¶ ( Park Jung-Chul ) - ¿¬¼¼´ëÇб³ Ä¡°ú´ëÇÐ Ä¡ÁÖ°úÇб³½Ç
±è¿ëÅ ( Kim Yong-Tae ) - ¿¬¼¼´ëÇб³ Ä¡°ú´ëÇÐ Ä¡ÁÖ°úÇб³½Ç
Á¤ÀÓÈñ ( Jung Im-Hee ) - ¿¬¼¼´ëÇб³ Ä¡°ú´ëÇÐ Ä¡ÁÖ°úÇб³½Ç
¾öÀ¯Á¤ ( Um Yoo-Jung ) - ¿¬¼¼´ëÇб³ Ä¡°ú´ëÇÐ Ä¡ÁÖ°úÇб³½Ç
Á¤ÀÇ¿ø ( Jung Ui-Won ) - ¿¬¼¼´ëÇб³ Ä¡°ú´ëÇÐ Ä¡ÁÖ°úÇб³½Ç
±è⼺ ( Kim Chang-Sung ) - ¿¬¼¼´ëÇб³ Ä¡°ú´ëÇÐ Ä¡ÁÖ°úÇб³½Ç
Á¶±Ô¼º ( Cho Kyoo-Sung ) - ¿¬¼¼´ëÇб³ Ä¡°ú´ëÇÐ Ä¡ÁÖ°úÇб³½Ç
äÁß±Ô ( Chae Jung-Kiu ) - ¿¬¼¼´ëÇб³ Ä¡°ú´ëÇÐ Ä¡ÁÖ°úÇб³½Ç
±èÁ¾°ü ( Kim Chong-Kwan ) - ¿¬¼¼´ëÇб³ Ä¡°ú´ëÇÐ Ä¡ÁÖ°úÇб³½Ç
ÃÖ¼ºÈ£ ( Choi Seong-Ho ) - ¿¬¼¼´ëÇб³ Ä¡°ú´ëÇÐ Ä¡ÁÖ°úÇб³½Ç

Abstract

2001³â Piot µî1)ÀÇ º¸°í¿¡ ÀÇÇϸé Àü¼¼°èÀûÀ¸·Î 3õ 5¹é¸¸ ¸íÀÌ HIV(Human immunodeficiency virus)¿¡ °¨¿°µÇ¾ú°í ÀÌ Áß 2õ¸¸ ¸íÀÌ »ç¸ÁÇß´Ù. ¹Ì±¹ Áúº´°ü¸®º»ºÎÀÇ ÃÖ±Ù º¸°í¿¡ µû¸£¸é ¹Ì±¹ ³»¿¡´Â ÇöÀç 1¹é¸¸ ¸íÀÇ HIV °¨¿°ÀÚ°¡ Á¸ÀçÇÏ¸ç ¸Å³â 4¸¸ ¸íÀÌ Ãß°¡ °¨¿°µÇ°í ÀÖ´Ù°í ÇÑ´Ù. ´õ¿íÀÌ °¨¿°ÀÚ Áß 24~27 %°¡ ÀÚ½ÅÀÇ °¨¿° ¿©ºÎ¸¦ ¸ð¸£°í ÀÖ¾ú´Ù°í ÇÑ´Ù2). °ú°Å ¿ì¸®¿Í´Â ¹«°üÇÑ ÀÏ·Î Ä¡ºÎµÇ´ø HIV °¨¿° ¹× AIDS(acquired immunodeficiency syndrome)´Â 1985³â 6¿ù ÃÖÃÊ È¯ÀÚ°¡ º¸°íµÈ ÀÌ·¡ Á¡Â÷ °¨¿° È®»ê ½Ã±â·Î ÁøÀÔÇÏ¿´°í3), 2008³â 12¿ù ¸» ±¹³» ´©Àû HIV °¨¿°ÀÚÀÇ ¼ö´Â 6,120¸íÀ¸·Î ÀÌÁß 1,084¸íÀÌ »ç¸ÁÇß°í, 5,036¸íÀÌ »ýÁ¸ÇØ ÀÖÀ¸¸ç ÀáÀçÀûÀ¸·Î 5¹è ÀÌ»óÀÇ HIV °¨¿°ÀÚ°¡ Á¸ÀçÇÒ °ÍÀ¸·Î ÃßÁ¤µÈ´Ù°í Áúº´°ü¸®º»ºÎ°¡ ¹àÇû´Ù. ƯÈ÷ ÃÖ±Ù ÃæûºÏµµ Á¦ÃµÀÇ ÇÑ Åýà ±â»ç°¡ HIV °¨¿°¿¡µµ ºÒ±¸ÇÏ°í ÃÖ±Ù 6³â°£ ÇÇÀÓ ±â±¸ ¾øÀÌ ¼ö½Ê ¸íÀÇ ¿©¼º°ú ¼º°ü°è¸¦ °¡Áø °ÍÀ¸·Î ¹àÇôÁ® »çȸÀû Ãæ°ÝÀ» ºÒ·¯ ÀÏÀ¸Ä×´Ù. ÀÌÁ¦ ¿ì¸® ³ª¶óµµ HIV °¨¿°À¸·ÎºÎÅÍ ¾È½ÉÇÒ ¼ö ¾ø´Â »óȲÀÌ µÇ¾ú´Ù. AIDS´Â ÃÖÃÊ HIV °¨¿° ÈÄ¿¡µµ Àẹ±â°¡ ÃÖ°í 8~10³â±îÁö Áö¼ÓµÉ ¼ö ÀÖ¾î, ȯÀÚ°¡ ÀÚ½ÅÀÇ °¨¿° ¿©ºÎ¸¦ ÀÚ°¢ÇÏÁö ¸ø ÇÏ°í ÀÚ½ÅÀÇ Çൿ ½À°üÀ» À¯ÁöÇÒ °¡´É¼ºÀÌ ¸Å¿ì ³ôÀº ÁúȯÀÌ´Ù. ¿¬±¸¿¡ µû¸£¸é ½Å±Ô °¨¿°ÀÇ 55%°¡ ÀÚ½ÅÀÇ °¨¿° ¿©ºÎ¸¦ ¸ô¶ú´ø 25%ÀÇ HIV º¸±ÕÀڵ鿡 ÀÇÇØ ¹ß»ýÇÏ´Â °ÍÀ¸·Î ¹àÇôÁ³´Ù4). µû¶ó¼­ HIV °¨¿°ÀÚÀÇ Á¶±â »öÃâ(screening)À» ÅëÇØ ÀáÀçÀûÀÎ HIV °¨¿°ÀÚ¸¦ ¹ß°ßÇÏ´Â °ÍÀÌ ¿ä±¸µÇ°í ÀÖ´Ù. Áö³­ 2006³â ¹Ì±¹ Áúº´°ü¸®º»ºÎ(CDC)´Â ¸ðµç ÀÇ·á±â°ü¿¡¼­ 13-64¼¼ ȯÀÚ¸¦ ´ë»óÀ¸·Î ȯÀÚ ¼­¸é µ¿ÀÇ ¾øÀÌ ¼ö¼ú Àü »çÀü °Ë»ç·Î ¹Ýµå½Ã HIV °Ë»ç ½ÃÇàÀ» ±ÇÀåÇÏ´Â ±Ç°í¾ÈÀ» ¹ßÇ¥Çß´Ù. ¶ÇÇÑ 2008³â ¹Ì±¹ ÀÇ»çÇùȸ´Â HIV¿¡ °¨¿°µÉ ¿ì·Á°¡ ÀÖ´Â À§ÇèÇÑ ÇൿÀÇ ¿©ºÎ¿Í °ü°è¾øÀÌ 13¼¼ ÀÌ»óÀÇ ¸ðµç ȯÀڵ鿡°Ô Á¤±âÀûÀ¸·Î HIV °Ë»ç¸¦ ½Ç½ÃÇØ¾ß ÇÑ´Ù°í ±ÇÀåÇß´Ù. ÀÌ¿Í °°Àº ÀÇ·á°èÀÇ Àû±ØÀûÀÎ °³ÀÔÀÇ ¹è°æ¿¡´Â AIDS ¹ßº´ ÀÌÈÄÀÇ Ä¡·áº¸´Ù Á¶±â »öÃâÀ» ÅëÇÑ Ãʱâ óġ°¡ Ä¡·á ¿¹Èĵµ ÁÁÀ» »Ó ¾Æ´Ï¶ó ¸·´ëÇÑ ÀÇ·á ºñ¿ë Àý°¨ È¿°ú°¡ ÀÖ´Ù´Â º¸°Ç Á¤Ã¥ »óÀÇ Àǹ̵µ Á¸ÀçÇÑ´Ù. ÀÌ´Â ¹Ì±¹»Ó ¾Æ´Ï¶ó ¸¹Àº ±¹°¡µéÀÌ Á¡Â÷ µû¸£°Ô µÉ ¼ö¼øÀ¸·Î »ç·áµÈ´Ù. ±âÁ¸ÀÇ AIDS ¹× HIV Ç×ü °Ë»ç´Â ÀÇ·á ±â°ü¿¡¼­ Àǹ«·Î ½ÃÇàÇÏÁö ¾Ê¾Æ ȯÀÚµéÀÇ °Ë»ç È£ÀÀµµ°¡ ³ôÁö ¾Ê¾Ò´Ù5). ÇÏÁö¸¸ Àǹ«°¡ ¾Æ´Ï¶ó´Â ÀÌÀ¯»Ó ¾Æ´Ï¶ó äÇ÷ °Ë»ç¶ó´Â ÅëÁõÀ» À¯¹ßÇÏ´Â ¹æ¹ýÀÌ È¯Àڵ鿡°Ô ¸¹Àº ºÎ´ãÀ» ÁÖ¾ú´ø °ÍÀÌ »ç½ÇÀÌ°í, °Ë»ç °á°ú¸¦ º¸±â À§ÇØ Àç³»¿øÇØ¾ß ÇÑ´Ù´Â ¹ø°Å·Î¿ò ¶ÇÇÑ È¯ÀÚµéÀÇ ³·Àº È£ÀÀµµÀÇ ÇÑ ¿øÀÎÀ̾ú´Ù. ½ÇÁ¦·Î ÃÖ±Ù ¿¬±¸¿¡ ÀÇÇÏ¸é ±âÁ¸ÀÇ °Ë»ç ¹æ¹ýº¸´Ù ½Å¼Ó ±¸°­ Á¡¸· µµ¸» °Ë»ç ½Ã 1.5~2.2¹è ¼øÀÀµµ°¡ ³ô¾Ò´Ù°í ÇÑ´Ù6). ´Ù¸¥ ¿¬±¸¿¡¼­´Â ºÐ¸¸½Ç¿¡¼­ ½Å¼Ó °Ë»ç¿¡ ´ëÇÑ ¼øÀÀµµ°¡ °¡Àå ³ô¾ÒÀ¸¸ç7) ÀÀ±Þ½Ç ³»¿ø°´ Áß 56%°¡ ½Å¼Ó ±¸°­ Á¡¸· µµ¸» °Ë»ç¿¡ ÀÀÇß´Ù°í ÇÑ´Ù. ÀÌ·± ¹æ½ÄÀÇ °Ë»ç´Â HIV À¯º´·üÀÌ 0.2% ÀÌ»óÀÎ Áö¿ª¿¡¼­ ±âÁ¸ÀÇ Ç÷û °Ë»ç°¡ °¡Áö´Â ¹ø°Å·Î¿òÀ̳ª °æÁ¦Àû ¹®Á¦Á¡ µéÀ» ±Øº¹ÇÒ ¼ö ÀÖ´Â º¸ÆíÀû °Ë»ç·Î ȯ¿µ ¹Þ°í ÀÖ´Ù8). Àü¼úÇßµíÀÌ ¹Ì±¹ Áúº´°ü¸®º»ºÎ´Â ¸ðµç ÀÇ·á ±â°ü¿¡¼­ ½Å¼Ó HIV °Ë»ç¸¦ ½ÃÇàÇÒ °ÍÀ» ±Ç°íÇß°í, ƯÈ÷ Ä¡°ú Áø·á½ÇÀÌ »ó´çÇÑ Á߿伺À» °¡Áø Àå¼Ò·Î ºÎ°¢µÇ°í ÀÖ´Ù. ±× ÀÌÀ¯´Â Ä¡°úÀÇ»çµéÀÌ È¯ÀÚÀÇ ±¸°­ ³» ¼Ò°ßÀ» ÅëÇØ HIV °¨¿°À» °¡Àå ¸ÕÀú ½Äº°ÇÒ ¼ö ÀÖÀ¸¸ç, Ä¡·á ºÎÀ§°¡ µÇ´Â ±¸°­ ºÎÀ§°¡ ½Å¼Ó °Ë»çÀÇ ºÎÀ§¿Í µ¿ÀÏÇÏ´Ù´Â Á¡¿¡¼­ °Ë»çÀÇ ¿ëÀ̼º ¹× ȯÀÚÀÇ ³ôÀº ¼øÀÀµµ¸¦ À̲ø¾î ³¾ ¼ö Àֱ⠶§¹®ÀÌ´Ù. ÇÑ ¿¬±¸¿¡ ÀÇÇϸé ÀڽŵéÀÇ ¼ö°í¸¦ ÅëÇØ HIV °¨¿°ÀÚÀÇ »öÃâÀÌ °¡Á® ¿À´Â °ø°ø º¸°Ç¿¡ÀÇ ±â¿©´Â ¹°·Ð ¼úÀÚ¿Í ½ºÅÂÇÁµéÀÇ °Ç°­À» º¸È£ÇÒ ¼ö ÀÖ´Ù´Â Á¡ µîÀ¸·Î ÀÎÇØ 30% ÀÌ»óÀÇ Ä¡°úÀÇ»çµéÀÌ ÀÚ½ÅÀÇ Áø·á½Ç¿¡¼­ °Ë»ç¸¦ Á¦°øÇÏ°Ú´Ù°í Çß´Ù. ÇÏÁö¸¸ °Ë»ç Á¦°øÀ» ¸Á¼³ÀÌ´Â Ä¡°úÀÇ»çµéÀº ±× ÀÌÀ¯·Î »ó´ã ´É·ÂÀÇ ºÎÁ·, ȯÀÚ ¼øÀÀµµ ºÎÁ·, ½Ã°£Àû Á¦¾à, °Ë»ç ¼÷·Ãµµ ºÎÁ· µîÀ» ²Å¾Ò´Ù°í ÇÑ´Ù9). Ä¡°ú ¿µ¿ª¿¡¼­ÀÇ ½Å¼Ó ±¸°­ Á¡¸· µµ¸» HIV Ç×ü °Ë»ç µµÀÔÀÌ Ä¡°úÀÇ»ç´Â ¹°·Ð Ä¡°ú Áø·á½ÇÀ» ã´Â ȯÀڵ鿡°Ô ÁÖ´Â Àǹ̿¡ ´ëÇؼ­ ¸¹Àº ¿¬±¸°¡ ÁøÇàµÈ ¹Ù ¾ø´Ù. º» ³í¹®ÀÇ ¸ñÀûÀº HIV ½Å¼Ó ±¸°­ Á¡¸· µµ¸» HIV Ç×ü °Ë»ç¿¡ ´ëÇÑ Ä¡°úÀÇ»çµé°ú ȯÀÚµéÀÇ ÀÇ½Ä ¼öÁØ°ú ŵµ¸¦ »ìÇǸç, ´õºÒ¾î HIV °¨¿° ¹× AIDS Áúȯ¿¡ ´ëÇÑ ÀϹÝÀûÀÎ Áö½Ä ¼öÁØ¿¡ ´ëÇØ °íÂûÇÏ°íÀÚ ÇÔÀÌ´Ù.

Purpose :The aim of this study was to evaluate the patient¡¯s and dentist¡¯s perspective and knowledge on rapid human immunodeficiency virus screening test in dental setting.

Materials and Methods :In March 2009, 100 patients and 100 dentists at Department of Periodontology, College of Dentistry, Yonsei University were provided an attitude assessment survey.

Results :Results were analyzed for acceptance of testing and potential barriers. 94% of patients agreed to take a rapid HIV screening test and 77% of dentists were willing to provide the test to their patients. Also the current knowledge state of patients and dentists on HIV infection was not accurate as expected.

Conclusion :Overall, dental clinic patients widely accepted the offer of rapid oral HIV screening. Rapid HIV screening test in the dental setting can be an important option to increase the number of individuals who know their HIV status.

Å°¿öµå

HIV;AIDS;rapid oral HIV screening.

¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸

 

µîÀçÀú³Î Á¤º¸

KCI